• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

PAVmed Inc. - Common Stock (NQ:PAVM)

7.290 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Jan 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about PAVmed Inc. - Common Stock

< Previous 1 2 3 Next >
News headline image
PAVmed and Lucid Diagnostics Provide Strategic Business Update
January 17, 2023
From PAVmed Inc.
Via Business Wire
News headline image
PAVmed and Lucid Diagnostics to Provide Strategic Business Update
January 11, 2023
From PAVmed Inc.
Via Business Wire
News headline image
PAVmed Partners with Novosound on Ultrasound Imaging Technology
December 22, 2022
From PAVmed Inc.
Via Business Wire
News headline image
Lucid Diagnostics Selected as Finalist for Medtech Company of the Year 2022 by Medical Device + Diagnostic Industry
December 08, 2022
From Lucid Diagnostics Inc.
Via Business Wire
News headline image
PAVmed Digital Health Subsidiary Veris Health Launches Veris Cancer Care Platform
December 15, 2022
From PAVmed Inc.
Via Business Wire
News headline image
Lucid Diagnostics Presents Real-World EsoCheck Data at the American Association for Cancer Research
December 01, 2022
From Lucid Diagnostics Inc.
Via Business Wire
News headline image
PAVmed Provides Business Update and Third Quarter 2022 Financial Results
November 15, 2022
From PAVmed Inc.
Via Business Wire
News headline image
Lucid Diagnostics Provides Business Update and Third Quarter 2022 Financial Results
November 14, 2022
From Lucid Diagnostics Inc.
Via Business Wire
News headline image
PAVmed to Participate in BTIG Digital Health Forum
November 11, 2022
From PAVmed Inc.
Via Business Wire
News headline image
Lucid Diagnostics Commences Production of EsoCheck Devices with High-Volume Manufacturer
November 09, 2022
From Lucid Diagnostics Inc.
Via Business Wire
News headline image
Lucid Diagnostics to Participate in Canaccord Genuity’s MedTech, Diagnostics and Digital Health & Services Forum
November 10, 2022
From Lucid Diagnostics Inc.
Via Business Wire
News headline image
PAVmed to Hold a Business Update Conference Call and Webcast on November 15, 2022
November 03, 2022
From PAVmed Inc.
Via Business Wire
News headline image
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 14, 2022
November 02, 2022
From Lucid Diagnostics Inc.
Via Business Wire
News headline image
PAVmed Provides Business Update and Preliminary Second Quarter 2022 Financial Results
August 16, 2022
From PAVmed Inc.
Via Business Wire
News headline image
PAVmed to Participate in the Lake Street 6th Annual Best Ideas Growth Conference and the A.G.P. Virtual MedTech Conference
August 30, 2022
From PAVmed Inc.
Via Business Wire
News headline image
Lucid Diagnostics Provides Business Update and Preliminary Second Quarter 2022 Financial Results
August 15, 2022
From Lucid Diagnostics Inc.
Via Business Wire
News headline image
Lucid Diagnostics Launches Stage II Lucid Test Center Expansion in California, Texas, Florida, and Ohio
August 11, 2022
From Lucid Diagnostics Inc.
Via Business Wire
News headline image
Newly Published American Gastroenterological Association Clinical Practice Update Supports Esophageal Precancer Screening Using Lucid Diagnostics’ EsoGuard® and EsoCheck® Technologies
August 04, 2022
From Lucid Diagnostics Inc.
Via Business Wire
News headline image
PAVmed to Hold a Business Update Conference Call on August 16, 2022
August 03, 2022
From PAVmed Inc.
Via Business Wire
News headline image
PAVmed Chairman & CEO Lishan Aklog, M.D. Named to Savoy’s 2022 Most Influential Black Executives in Corporate America
July 19, 2022
From PAVmed Inc.
Via Business Wire
News headline image
Lucid Diagnostics to Participate in the Canaccord 42nd Annual Growth Conference and the 7th Annual Needham Med Tech & Diagnostics 1x1 Conference
July 18, 2022
From Lucid Diagnostics Inc.
Via Business Wire
News headline image
PAVmed PAVmed Provides Business Update and Preliminary First Quarter 2022 Financial Results
May 12, 2022
From PAVmed Inc.
Via Business Wire
News headline image
PAVmed and Lucid Diagnostics Chairman & CEO Lishan Aklog, M.D. Named Top 50 Healthcare Technology CEO
May 13, 2022
From PAVmed Inc.
Via Business Wire
News headline image
Lucid Diagnostics Provides Business Update and Preliminary First Quarter 2022 Financial Results
May 11, 2022
From Lucid Diagnostics Inc.
Via Business Wire
News headline image
Lucid Diagnostics’ Laboratory Executes Participating Provider Agreement with MediNcrease Health Plans
May 09, 2022
From Lucid Diagnostics Inc.
Via Business Wire
News headline image
PAVmed to Hold a Business Update Conference Call on May 12, 2022
April 26, 2022
From PAVmed Inc.
Via Business Wire
News headline image
Lucid Diagnostics to Hold a Business Update Conference Call on May 11, 2022
April 25, 2022
From Lucid Diagnostics Inc.
Via Business Wire
News headline image
PAVmed Provides Business Update and Preliminary Fourth Quarter and Full Year 2021 Financial Results
March 29, 2022
From PAVmed Inc.
Via Business Wire
News headline image
Lucid Diagnostics Provides Updates on Newly Published Esophageal Precancer Clinical Guideline and Proposed Medicare Local Coverage Determination
April 04, 2022
From Lucid Diagnostics Inc.
Via Business Wire
News headline image
Lucid Diagnostics to Participate in the Needham 21st Annual Healthcare Conference
March 30, 2022
From Lucid Diagnostics Inc.
Via Business Wire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap